Sirona Biochem (STU:ZSB) OCF Margin %: -18,600.00% (As of Jul. 2024)


What is Sirona Biochem OCF Margin %?

Sirona Biochem STU:ZSB OCF Margin % is -18,600.00% as of Jul. 2024.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Sirona Biochem's Cash Flow from Operations for the three months ended in Jul. 2024 was €-0.37 Mil. Sirona Biochem's Revenue for the three months ended in Jul. 2024 was €0.00 Mil. Therefore, Sirona Biochem's OCF Margin % for the quarter that ended in Jul. 2024 was -18,600.00%.

As of today, Sirona Biochem's current OCF Yield % is -14.20%.

The historical rank and industry rank for Sirona Biochem's OCF Margin % or its related term are showing as below:

STU:ZSB' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 11483.33

STU:ZSB's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -66.52 vs STU:ZSB: 11483.33

Sirona Biochem OCF Margin % Related Terms

Sirona Biochem OCF Margin % Historical Data

* Premium members only.

The historical data trend for Sirona Biochem's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sirona Biochem OCF Margin % Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,622.58 -1,997.06 -804.30 -324.30 -5,058.33

Sirona Biochem Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,380.00 759.09 -37,100.00 -6,685.71 -18,600.00

STU:ZSB vs MTNB, TCRT, QLGN: OCF Margin % Comparison

For the Biotechnology subindustry, Sirona Biochem's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sirona Biochem OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's OCF Margin % falls into.


Sirona Biochem OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Sirona Biochem's OCF Margin for the fiscal year that ended in Oct. 2023 is calculated as

OCF Margin=Cash Flow from Operations (A: Oct. 2023 )/Revenue (A: Oct. 2023 )
=-1.214/0.024
=-5,058.33 %

Sirona Biochem's OCF Margin for the quarter that ended in Jul. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jul. 2024 )/Revenue (Q: Jul. 2024 )
=-0.372/0.002
=-18,600.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -18,600.00% mean?
Sirona Biochem (STU:ZSB) has a OCF Margin % of -18,600.00% as of Jul. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sirona Biochem and its competitors.
Is Sirona Biochem's OCF Margin % too high?
Sirona Biochem's current OCF Margin % is -18,600.00%.
How does Sirona Biochem's OCF Margin % compare to MTNB and TCRT?
Sirona Biochem's OCF Margin % of -18,600.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sirona Biochem and its competitors. Sirona Biochem's current OCF Margin % is -18,600.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sirona Biochem stock overvalued right now?
Sirona Biochem (STU:ZSB) has a current OCF Margin % of -18,600.00%. The current OCF Margin % is -18,600.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Sirona Biochem (STU:ZSB), the current OCF Margin % is -18,600.00% as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sirona Biochem Business Description

Address C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L4
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.